FindMyRecallSubscribe
Class I: serious health riskTerminated

Medisca Human Chorionic Gonadotropin Recall

Human Chorionic Gonadotropin, EP (HCG) in 5 mu

Medisca Inc. · Irving, TX

Risk level
Class I
Reported by FDA
May 7, 2014
Recall ID
D-1263-2014
Check your lot numberHow we source this data

Summary

Medisca recalled Human Chorionic Gonadotropin starting Oct 21, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-1263-2014 on May 7, 2014. Reason: Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.

Product description

Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law. Potency 5489.6IU/mg. Packed by Medisca, Inc. Irving, TX, 75063, USA NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6. Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3

Lot numbers, UPCs & expiration codes

Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3. NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1263-2014
Classification
Class I
Status
Terminated
Recall initiated
Oct 21, 2013
FDA report date
May 7, 2014
Quantity
296 units
Recall type
Voluntary: Firm initiated
Recalling firm
Medisca Inc.

Original FDA data

Every field from FDA enforcement report D-1263-2014, exactly as published.

Show all FDA fields
City
Irving
State
TX
Status
Terminated
Country
United States
Event ID
67114
Address
8300 Esters Blvd Ste 940
Code information
Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3. NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.
Postal code
75063-2272
Report date
May 7, 2014
Product type
Drugs
Recall number
D-1263-2014
Classification
Class I
Recalling firm
Medisca Inc.
Product quantity
296 units
Termination date
Nov 16, 2016
Reason for recall
Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law. Potency 5489.6IU/mg. Packed by Medisca, Inc. Irving, TX, 75063, USA NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6. Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3
Distribution pattern
Nationwide
Recall initiation date
Oct 21, 2013
Initial firm notification
Letter
Center classification date
Apr 25, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1263-2014, published May 7, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls